These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 3123283

  • 1. [Effect of oral administration of L-dopa on the plasma levels of growth hormone-releasing hormone (GHRH) in normal subjects and patients with various endocrine and metabolic diseases].
    Mitsuhashi S, Yamasaki R, Miyazaki S, Saito H, Saito S.
    Nihon Naibunpi Gakkai Zasshi; 1987 Aug 20; 63(8):934-46. PubMed ID: 3123283
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of hypothalamic-pituitary function in a combination of tests with four hypothalamic releasing hormones and L-dopa in normal subjects and in patients with hypothalamic and/or pituitary disorders.
    Bando H, Yamasaki R, Saito S.
    Endocrinol Jpn; 1989 Oct 20; 36(5):705-20. PubMed ID: 2559840
    [Abstract] [Full Text] [Related]

  • 3. Secretion of growth hormone-releasing hormone in patients with idiopathic pituitary dwarfism and acromegaly.
    Yamasaki R, Saito H, Kameyama K, Hosoi E, Saito S.
    Acta Endocrinol (Copenh); 1988 Mar 20; 117(3):273-81. PubMed ID: 2898191
    [Abstract] [Full Text] [Related]

  • 4. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P, Knip M, Lautala P, Leppäluoto J.
    J Clin Endocrinol Metab; 1988 Oct 20; 67(4):845-9. PubMed ID: 3138280
    [Abstract] [Full Text] [Related]

  • 5. Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children.
    Donnadieu M, Evain-Brion D, Tonon MC, Vaudry H, Job JC.
    J Clin Endocrinol Metab; 1985 Jun 20; 60(6):1132-4. PubMed ID: 3923020
    [Abstract] [Full Text] [Related]

  • 6. Ectopic growth hormone-releasing hormone (GHRH) syndrome in a case with multiple endocrine neoplasia type I.
    Yamasaki R, Saito H, Sano T, Kameyama K, Yoshimoto K, Hosoi E, Matsumura M, Harada K, Saito S.
    Endocrinol Jpn; 1988 Feb 20; 35(1):97-109. PubMed ID: 2899505
    [Abstract] [Full Text] [Related]

  • 7. Impaired secretion of growth hormone-releasing hormone, growth hormone and IGF-I in elderly men.
    Bando H, Zhang C, Takada Y, Yamasaki R, Saito S.
    Acta Endocrinol (Copenh); 1991 Jan 20; 124(1):31-6. PubMed ID: 2000699
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone releasing hormone 1-44 NH2 and 1-40 OH levels in normal subjects during growth hormone stimulation tests.
    Page MD, Dieguez C, Valcavi R, Koppeschaar HP, Scanlon MF.
    Clin Endocrinol (Oxf); 1994 Jan 20; 40(1):97-102. PubMed ID: 8306488
    [Abstract] [Full Text] [Related]

  • 9. Immunoreactive growth hormone-releasing hormone (IR-GHRH) in the feto-placental circulation and differential effects of L-dopa, L-arginine and somatostatin-14 on the plasma levels of IR-GHRH in normal adults.
    Saito H, Hosoi E, Yamasaki R, Kameyama K, Irahara M, Ohno Y, Saito S.
    Horm Metab Res; 1997 Apr 20; 29(4):184-9. PubMed ID: 9178029
    [Abstract] [Full Text] [Related]

  • 10. Impaired response of growth hormone-releasing hormone (GHRH) measured in plasma after L-dopa stimulation in patients with idiopathic delayed puberty.
    Argente J, Evain Brion D, Donnadieu M, Garnier P, Vaudry H, Job JC.
    Acta Paediatr Scand; 1987 Mar 20; 76(2):266-70. PubMed ID: 3109206
    [Abstract] [Full Text] [Related]

  • 11. Plasma growth hormone releasing factor levels in children: physiological and pharmacologically induced variations.
    Brion DE, Donnadieu M, Liapi C, Argente J, Tonon MC, Garnier P, Job JC.
    Horm Res; 1986 Mar 20; 24(2-3):116-20. PubMed ID: 3093352
    [Abstract] [Full Text] [Related]

  • 12. L-dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans.
    Chihara K, Kashio Y, Kita T, Okimura Y, Kaji H, Abe H, Fujita T.
    J Clin Endocrinol Metab; 1986 Mar 20; 62(3):466-73. PubMed ID: 3080462
    [Abstract] [Full Text] [Related]

  • 13. Effect of oral glucose administration on plasma growth hormone-releasing hormone (GHRH)-like immunoreactivity levels in normal subjects and patients with idiopathic GH deficiency: evidence that GHRH is released not only from the hypothalamus but also from extrahypothalamic tissue.
    Kashio Y, Chihara K, Kita T, Okimura Y, Sato M, Kadowaki S, Fujita T.
    J Clin Endocrinol Metab; 1987 Jan 20; 64(1):92-7. PubMed ID: 3097059
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment.
    Page MD, Dieguez C, Valcavi R, Edwards C, Hall R, Scanlon MF.
    Clin Endocrinol (Oxf); 1988 May 20; 28(5):551-8. PubMed ID: 3145820
    [Abstract] [Full Text] [Related]

  • 15. Stimulated growth hormone (GH) secretion in children with delays in pubertal development before and after the onset of puberty: relationship with peripheral plasma GH-releasing hormone and somatostatin levels.
    Saggese G, Cesaretti G, Giannessi N, Bracaloni C, Cinquanta L, Cioni C.
    J Clin Endocrinol Metab; 1992 Feb 20; 74(2):272-8. PubMed ID: 1346143
    [Abstract] [Full Text] [Related]

  • 16. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome].
    Schmitt K, Schober E, Birnbacher R, Frisch H.
    Klin Padiatr; 1996 Feb 20; 208(1):29-34. PubMed ID: 8851324
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of impaired growth hormone secretion in patients with Cushing's disease.
    Takahashi H, Bando H, Zhang C, Yamasaki R, Saito S.
    Acta Endocrinol (Copenh); 1992 Jul 20; 127(1):13-7. PubMed ID: 1519417
    [Abstract] [Full Text] [Related]

  • 18. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects.
    Hanew K, Tanaka A, Utsumi A, Sugawara A, Abe K.
    J Clin Endocrinol Metab; 1996 May 20; 81(5):1952-5. PubMed ID: 8626863
    [Abstract] [Full Text] [Related]

  • 19. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1989 Feb 20; 68(2):290-3. PubMed ID: 2493023
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M, Schopohl J, König A, Müller OA, von Werder K.
    J Clin Endocrinol Metab; 1986 Aug 20; 63(2):475-80. PubMed ID: 3088026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.